Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects. [electronic resource]
Producer: 20080418Description: 85-95 p. digitalISSN:- 0091-2700
- Adamantane -- administration & dosage
- Administration, Oral
- Adult
- Amlodipine -- administration & dosage
- Angiotensin II Type 1 Receptor Blockers -- administration & dosage
- Angiotensin-Converting Enzyme Inhibitors -- administration & dosage
- Antihypertensive Agents -- administration & dosage
- Area Under Curve
- Cross-Over Studies
- Dipeptidyl-Peptidase IV Inhibitors -- administration & dosage
- Drug Interactions
- Female
- Half-Life
- Headache -- chemically induced
- Humans
- Male
- Middle Aged
- Nausea -- chemically induced
- Nitriles -- administration & dosage
- Pyrrolidines -- administration & dosage
- Ramipril -- administration & dosage
- Tablets
- Tetrazoles -- administration & dosage
- Valine -- administration & dosage
- Valsartan
- Vildagliptin
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.